COMP <GO>
CNS vs JPM // RETURN ON INVESTED CAPITAL (ROIC)
Cohen & Steers Inc (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: CNS 3
— JPM 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CNS
LAST: $72.91 (+4.08%) • MKT CAP: $3.75B
roic
33.70%
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
roic
17.37%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNS VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNS | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 33.70% | 17.37% | +16.33 | CNS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.7x | 9.7x | +10.03 | JPM | /valuation <GO> |
| Free Cash Flow Yield | -3.37% | -18.14% | +14.77 | CNS | /fcf-yield <GO> |
| Operating Margin | — | 42.07% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 32.63% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 13.53% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.39% | 1.96% | +1.43 | CNS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.1 | 55.1 | -3.00 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.8x | 13.6x | +9.23 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.75B | $913.30B | -$909.55B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNS REV | JPM REV | CNS GROSS % | JPM GROSS % | CNS FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $182.45B | — | — | -$126.4M | -$147.78B |
| FY 2024 | $0 | $177.56B | — | — | $85.0M | -$42.01B |
| FY 2023 | $0 | $158.10B | — | — | $172.0M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNS // BETA —
JPM // BETA 1.00